Now more than ever, NAMs need to be considered a core aspect of modern drug development – and scientists, decision-makers, regulators and governments must keep pace with this evolving landscape to ensure they are equipped to deliver the next-generation of therapies.
The post The Changing Landscape of New Approach Methodologies appeared first on MedCity News.
